175
Views
0
CrossRef citations to date
0
Altmetric
Editorials

Lipid profile screening in second-generation antipsychotic users: the gap between policy and practice

&
Pages 299-303 | Published online: 18 Jan 2017
 

Abstract

“Given the significant cardiometabolic risks associated with the use of second-generation antipsychotic drugs, it is particularly troubling that rates of dyslipidemia screening and monitoring are so low.”

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.